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SUMMARY
The aims of the study were to determine the prevalence of
peripheral arterial disease (PAD) in diabetic patients and in
different ethnic groups at a primary care setting, and to
evaluate risk factors associated with PAD in these diabetic
patients.  A cross sectional study of 200 diabetic patients
over 18 years old who attended a primary care clinic at a
teaching hospital in Kuala Lumpur, Malaysia was carried out.
Face-to-face interviews were conducted using structured
questionnaires for demographic characteristics and risk
factors evaluation.  Blood pressure measurements,
assessment of peripheral neuropathy and ankle brachial
pressures were performed.  PAD was diagnosed by an ankle
brachial pressure index (ABPI) of <0.9 on either leg.  The
overall prevalence of PAD was 16% in this diabetic
population.   The prevalence of PAD was 5.8% in Malays,
19.4% in Chinese and 19.8% in Indians.  The prevalence of
peripheral neuropathy was 41%, foot ulcer 9.5%, and
gangrene 3.0%.  The presence of foot ulcer was weakly
associated with PAD (P=0.052).  No significant relationships
were found between age, gender, smoking status, duration
of diabetes mellitus, hypertension, dyslipidaemia, and PAD.
PAD is common in the diabetic population of this study.
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INTRODUCTION
Peripheral arterial disease (PAD) is a vascular disease caused by
an occlusion of a peripheral arterial vessel that results in
ischaemia1,2.  Clinically it may manifest as intermittent
claudication and rest pain3.  It progresses more rapidly and is
more diffuse in patients with diabetes mellitus (DM)4.
Patients with Type 2 DM are 20 times more likely to develop
PAD of the lower extremities5.  The risk of lower extremity
amputation and mortality are also higher in diabetics
compared to non-diabetics6.  The American Diabetic
Association has estimated that 40-50% of the diabetic related
amputations are preventable5.  Therefore early detection of
PAD in the diabetic population is very important. 
The prevalence of PAD among patients with DM is found to
vary between 10-42%7-9.  However, no data is available on the
association of ethnicity and PAD in the diabetic population.
In the general population, Indians are found to have a higher
prevalence rate of PAD than other ethnic groups10.   Possible
risk factors for PAD in patients with DM include increasing
age, duration of DM, smoking, hypertension,
hyperlipidaemia and increased waist to hip ratio7-9. 
Ankle brachial pressure (ABPI) is an effective method used to
detect PAD11.  The sensitivity of ABPI is 90% and the
specificity is 98% for an angiographically defined stenosis of
50% or more in a major leg artery7.  However, in patients with
DM, the detection of PAD may be complicated by the
presence of peripheral neuropathy, as ischemic symptoms are
usually not felt due to reduced sensation, and the presence of
calcification of medial arteries12.
As no local data was found on the prevalence of PAD among
patients with DM in Malaysia, this study was undertaken to
determine the magnitude of the problem in patients with DM
of different ethnic groups, and to evaluate possible risk factors
of  PAD in these patients.
MATERIALS AND METHODS 
This was a cross sectional study on previously diagnosed
diabetic patients over 18 years of age who attended a primary
care clinic at a teaching hospital in Malaysia between March
and April 2004.  Approval was obtained from the hospital
ethics committee. 
All patients with DM who attended the clinic during the
study period were approached.  Of the 202 patients
approached, 200 agreed to participate giving a response rate
of 99%.  Participants were interviewed face to face using
structured questionnaires that included demographic
characteristics (age, gender, and ethnic group), risk factors
assessment, type and duration of DM, presence or absence of
diabetic foot lesions (ulcer, callus, foot deformity, gangrene,
amputation), history of smoking, hypertension, and
dyslipidaemia.  The results of HbA1C and lipid profile within
the previous 6 to 12 months were recorded. 
Blood pressure (BP) was measured in a resting position with a
mercury sphygmomanometer by auscultatory method.
Peripheral neuropathy was determined by assessing pain
(using a 5.07 Semmes Weinstein monofilament), vibration
sense, proprioception and light touch.  Ankle brachial
pressure was measured in a supine position with a 12-cm
occluding cuff placed above the ankle and a portable Doppler
device was used as the distal sensor at the dorsalis pedis and
posterior tibial arteries.  The brachial systolic BP was
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measured in both arms.  Ankle brachial pressure index (ABPI)
was calculated by dividing the higher reading of the ankle
pressures at the dorsalis pedis or posterior tibial artery, by the
brachial systolic pressure of the same side4.  PAD was defined
as ABPI < 0.9, while ABPI > 0.9 denotes absence of the disease.
ABPI > 1.3 suggests partial incompressibility of arteries, which
is likely to be due to medial arterial calcification. 
The data was analysed using SPSS version 11.5 for windows.
Chi square test was used to look for associations between
categorical variables and student’s t test was used for
continuous variable.  The level of significance was set at
p<0.05.
RESULTS
Two hundred patients with DM were enlisted.  Their
demographic characteristics are presented in Table I.  There
were more women (60.5%) than men in this population.  One
hundred and ninety-nine (99.5%) had type 2 DM.  Twelve
(6.0%) patients were current smokers.  Three quarter of the
patients had concurrent hypertension and more than half
had dyslipidaemia.  The prevalence of PAD was 16% (n=32,
ABPI < 0.9).  Out of the 168 patients that had ABPI > 0.9, 15
(8.9%) had ABPI ≥ 1.3, signifying the presence of medial
arterial calcification.  The prevalence of PAD among Malays
was 5.8%, Chinese 19.4%, and Indians 19.8%.  The
prevalence of peripheral neuropathy was 41%.   
Table II shows the association between possible risk factors
and PAD in diabetic patients.  There was no significant
association found between age, gender, ethnic groups,
duration of DM, HbA1C levels, gangrene, smoking,
hypertension, dyslipidaemia, and PAD in these diabetic
patients.  However, the presence of foot ulcer was weakly
associated with PAD (p=0.052). 
DISCUSSION
We found the prevalence of PAD in patients with DM in this
primary care setting to be 16%.  This is comparable to
findings of other studies, which varies from 10-15%7, 8.
Although the prevalence of PAD was lower in Malays than
Chinese and Indians, this was not statistically significant.  No
data is available to compare the prevalence of PAD in
different ethnic groups amongst diabetic population,
although in the general population, Chao et al found a higher
prevalence of PAD in Indians as compared to Chinese and
Malays10.  Another study found the prevalence of PAD to be
higher in African American compared to Whites and
Hispanics13.
The mean age of patients with PAD was 62+9.7 years.  There
was no significant relationship between age and PAD. Other
studies that found age as a risk factor for PAD were of older
population7-9.  Tseng showed that in Taiwanese Type 2
Parameters (n=200)
Mean age of total studied population (years) 61.10 + 9.82  
Mean age of male (years) 61.90 + 9.79
Mean age of female (years) 60.58 + 9.85
Gender
Male 79 (39.5%)
Female 121 (60.5%)
Ethnic group
Malay 52 (26.0%)
Chinese 62 (31.0%)
Indian 86 (43.0%)
Diabetes Mellitus
Duration (years) 10.72 + 7.56
HbA1C within last 6-12 months (%) 8.38 + 8.12
Smoking
Current smoker 12   (6.0%)
Ex-smoker 36 (18.0%)
Never smoke 152 (76.0%)
Prevalence of foot Lesion 28 (14.0%)
Foot Ulcer 19   (9.5%)
Gangrene 6   (3.0%)
Others (fungal infection)                                                                                 3   (1.5%)
Prevalence of hypertension 150 (75.0%)
Prevalence of dyslipidemia 112 (56.0%)
Lipid Profile 
Mean total cholesterol (mmol /L) 5.247 + 1.02 
Mean HDL-Cholesterol (mmol /L) 1.228 + 0.27 
Mean LDL-Cholesterol (mmol /L) 3.227 + 0.85 
Mean Triglyceride (mmol /L) 1.739 + 0.90 
Data are shown as no. of patients (%) or mean+ SD
Table I:  Demographics and Prevalence of different conditions
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diabetics, PAD was not common until the age of 65 years, and
thereafter the prevalence dramatically escalated in those aged
75 years and above7. 
The influence of the duration of DM on the occurrence of
diabetic macroangiopathy has been controversial7-9.  We did
not find any significant association between the duration of
DM and PAD in this diabetic population.  The United
Kingdom of Prospective Trial (UKPDS) showed that 50% of
their newly diagnosed type 2 diabetics had chronic
complications at diagnosis14.
Similarly the association between the control of DM and PAD
has been controversial8.  Again, we found no significant
association between HbA1C level5 and PAD, and this is in
concordance with some studies7,9,15.   We found no gender
difference in the prevalence of PAD in patients with DM
(male 13.9%, female 17.4%).  This concurred with other
studies7-9.  However; we found a weak association between
foot ulcer and PAD.  Oyibo had demonstrated that the
majority of diabetic patients with foot ulcers had clinical
evidence of PAD and peripheral neuropathy16.
Smoking is an important risk factor of PAD in the general
population.  We did not demonstrate any significant
association between smoking and PAD, a finding also of some
other students 7,9.    The high number of females recruited in
this study could have contributed to the low prevalence of
smoking (6%).  
The prevalence of hypertension and dyslipidemia were high
in both PAD and non-PAD groups in this study, suggesting
high cardiovascular risks in this population.  Some studies
have shown a strong relationship between systolic
hypertension and PAD7,8 but others have found no significant
association9.  We did not find any significant association
between hypertension or dyslipidaemia and PAD. 
More than half of the patients (53.1%) with PAD were found
to have concomitant peripheral neuropathy.  The presence of
PAD and peripheral neuropathy increases the risk of foot
complications5.  Therefore, early detection is important so
that preventive measures can be instituted.  
This study was limited by universal sampling and small
sample size.  The HbA1C level obtained from records was
done within the preceding six months.  This level would not
give an accurate reflection of patients’ diabetic control over
the years, as control would fluctuate.  However, it gave us an
indication of the control over a shorter period of time.  The
study recruits were from a primary care clinic of a tertiary
center.  Therefore, the findings may not reflect those in the
community and the results cannot be generalized to a
Malaysian diabetic population.  Nevertheless, these findings
provide an insight into the magnitude of this problem locally. 
CONCLUSION
The prevalence of PAD in this diabetic population was 16%.
There was a higher prevalence of PAD in Chinese, Indians
Risk Factors Prevalence of risk factors              p Value
No PAD (n=168) PAD (n=32)
Age 60.91 + 9.86 62.09 + 9.71 NS
Gender
Female 100 (59.5%) 21 (65.6%) NS
Male 68 (40.5%) 11 (34.4%)
Ethnic Group
Malay 49 (29.2%) 3   (9.4%) NS 
Chinese 50 (29.8%) 12 (37.5%)
Indian 69 (41.1%) 17 (53.1%)
Duration of DM 10.56 + 7.72 11.59 + 6.74 NS
HbA1C % 8.236 + 2.45 9.143 + 2.52 NS
Foot Lesion
Foot ulcer 13 (7.7%) 6 (18.8%) 0.052
Gangrene 5 (3.0%) 1 (3.1%) NS
Smoking
Current /Ex-smoker 38 (22.6%) 10 (31.3%) NS
Non-smoker 130 (77.4%) 22 (68.8%)
Hyperlipidemia 94 (56.0%) 18 (56.3%) NS
Total cholesterol 
Normal (<5.2) 21 (12.5%) 6  (18.8%) NS
Abnormal (>5.2) 147 (87.5%) 26 (81.3%)
Triglyceride
Normal (<1.7) 54 (32.1%) 7 (21.9%) NS
Abnormal (>1.7) 114 (67.9%) 25(78.1%)
HDL-C
Normal (>1.0) 138 (82.1%) 23 (71.9%) NS
Abnormal (<1.0) 30 (17.9%) 9 (28.1%)
LDL-C
Normal (<2.6) 21 (12.5%) 3   (9.4%) NS
Abnormal (>2.6) 147 (87.5%) 29 (90.6%)
Known Hypertensive 125 (74.4%) 25 (78.1%) NS
Peripheral Neuropathy 65 (38.7%) 17(53.1%) NS
NS: not significant
Data are shown as no. of patients (%) or mean+ SD
Table II: Association between Risk Factors and Peripheral Arterial Disease in patients with Diabetes Mellitus
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than Malays but this was not significant.  There was a weak
association between foot ulcer and PAD.
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